RecruitingNot ApplicableNCT06324942

Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.


Sponsor

University of Calgary

Enrollment

80 participants

Start Date

Feb 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to evaluate whether or not adding a Transversus Abdominis Plane Block (TAP block) improves pain control for patients having a cesarean section. A TAP block is a type of nerve block where at the end of the surgery an injection of a long acting local anesthetic is made into the abdominal wall. In studies in patient's having other abdominal surgeries this has reduced the amount of narcotics patients need for pain control. This may also led to patients being more active after surgery and maybe spending less time in hospital.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria2

  • ASA status II to III
  • All patients undergoing elective CS under regional anesthesia at any gestational age.

Exclusion Criteria7

  • \- Known drug allergy to local anesthetics
  • Planned general anesthetic
  • NSAID use contraindicated post partum
  • Chronic pain disorder or chronic narcotic use/dependence
  • Planned vertical abdominal incision
  • Planned Cesarean Hysterectomy.
  • Placenta Previa or suspected Placenta Accreta

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSurgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg

Surgeon-administered Transversus Abdominis Plane Block


Locations(1)

University of Calgary

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06324942


Related Trials